Acute Hepatic Encephalopathy And Multiorgan Failure In Sickle Cell Disease And Covid-19
PEDIATRIC BLOOD & CANCER(2021)
摘要
COVID-19 disease causes primarily pulmonary manifestations, with myriad other clinical manifestations especially in high-risk conditions, including sickle cell disease (SCD). We present a 19-year-old with SCD on deferasirox with COVID-19 infection involving pain and acute chest syndrome, four weeks later developing hyperammonemia and hyperinflammatory multiorgan failure. Successful treatment included hemodialysis, red cell exchange transfusion, and therapeutic plasma exchange. Though SCD-related multiorgan failure and deferasirox-related hyperammonemia are reported, this case suggests multifactorial etiology including COVID-19-related hyperinflammation. Awareness of potential hepatic and systemic complications, and consideration for exchange transfusion and therapeutic plasma exchange, may reduce severity of COVID-19 sequelae in SCD.
更多查看译文
关键词
sickle cell disease,hepatic encephalopathy
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要